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Prevalence
Depression in and within schizophrenia in 
common 
21-80%
• 7 to 70% 
• Wide range reflects how 
schizophrenia and depression was 
diagnosed
Epidemiology 
ECA patients meeting 
DSM III criteria for 
schizophrenia were 14 
to 28.5 times more likely 
to have a concurrent 
major depressive 
syndrome than general 
population
In NCS ,59% of patients 
with schizophrenia met 
DSM III R criteria for 
major or minor 
depression
Presentation and Nature of Depression 
as Syndrome in the clinical course
• As major depressive 
episode
• As frank manic episode
• As mixed states
• As dysphoric states
• As masked depression or 
somatized
• As suicidality
Co-existing co morbid depression & dysthiamia
Schizo-affective
Schizomanic
Schizo-obsessive
Schizophrenia 
spectrum
Major mood 
disorder
Bipolar disorder
Longitudinal 
course
Historical Phenomenological and 
diagnostic dilemma
schizophrenia
Affective 
Disorder
“It is increasingly becoming clear that we can not 
distinguish satisfactorily between these two illness 
and this brings home the suspicion that  our 
formulation of problem may be incorrect”
Kraepelin .E.
Affective symptoms as integral part of 
schizophrenia  across its course
Affective 
symptom 
Domain
Cognitive 
Symptom 
Domain
Negative 
Symptom 
Domain
Positive 
symptom 
Domain
Emergence of new diagnosis: 
Jacob kasonin 1933
The Third 
Psychosis: 
Schizoaffective 
Disorders
SchizophreniaAffective Disorder
Clinical overlap of schizophrenia spectrum and bipolar 
spectrum disorder
Current issues on schizoaffective disorder 
Encephale. 2005 
• Research on schizoaffective disorder has 
been marred by the variability of its 
definition. 
• Further studies are however still necessary, 
especially with regard to the subtyping of 
the disorder and its pharmacological 
treatment.
Are schizophrenia and affective 
disorder related?  2007 
 The Kraepelinian view of psychoses 
may need modification.
Best evidence of depression  in Schizophrenia and 
Correlation with of Neuroleptics comes  from 
epidemiology
( Johnson, 1981,Hirsch 1989,Hirsch 1973)
Depression occurs across the course of 
schizophrenia
‘Diagnostic Validity of Schizoaffective disorders’
Shrivastava A, Rao, S. IJP.1997
Current Evidence
Common neurobiological origin of 
‘Severe’ psychosis”
Bipolar Disorder: type I
Unipolar 
Depression with 
psychotic features
Schizophrenia
Related 
Symptom 
Cluster
Bipolar 
Spectrum
Depressive  
spectrum
Schizophrenia 
spectrum
Population 
Prevalence
3-4%
2%
0.7-1.4%
0.5-0.7%
Genotype Environmental unmasking
Multiple 
disease 
phenotypes
An Endophenotype of Schizophrenia
Schizophrenia 
spectrum
Social 
Unmasking
Psychologi
cal 
Unmaskin
g
Modifier 
Genes
Environm
ental
Susceptib
ility Gene
Genotype
Behavioral 
Traits-
Correlates
Life style 
issue
Risk factors
Brain 
Vulnerabil
ity
Essential 
Etiological 
factors
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Continuum of genetic liability to psychotic illness
Increasing neurodevelopmental impairment
Increasing genetic liability
Neuroendocrine:
Evidence for a neuromodulatory role for TRH
CSF thyrotropin-releasing hormone concentrations differ in patients with 
schizoaffective disorder from patients with schizophrenia or mood disorders, : 
Charles B. Nemeroffc Journal of Psychiatric Research
Volume 35, Issue 5, September-October 2001,
Schizoaffective disorder merges schizophrenia and bipolar disorders as one 
disease-
-there is no schizoaffective disorder
Curr Opin Psychiatry. 2007 Jul;.
Schizoaffective disorders are psychotic mood 
disorders; there are no schizoaffective disorders.
Psychiatry Res. 2006 Aug 
Does schizoaffective disorder really exist? 
middle point of a continuum between SCH and MD.
J Affect Disord. 2008 Mar

Insight
Depression
The 
Evidence
Why does depression occur in schizophrenia: Neurobiology
Depression in schizophrenia:. MRI and PET 
findings. Biol Psychiatry. 1998
The high depression group had larger bilateral 
temporal lobe volumes and decreased laterality 
(left minus right of metabolism in the anterior 
cingulate). 



• ↑ frequency & duration of hospitalization2
• ↑ risk of suicide3
• ↑ risk of relapse3
• ↑ impairment in social 
roles & relationships3
• ↑ unemployment4
Depression-suicide & Schizophrenia
Burden of Illness of Comorbid Depression in 
Schizophrenia
Depression in schizophrenia associated with lower 
QoL (n=67)1
Treatment Choice and Phase of illness

Current evidence: Anti Depressant Drugs
• The results provide weak evidence for the efficacy of 
antidepressants in patients with schizophrenia and 
depression.
• the only SSRI tested in the treatment of depression in 
schizophrenic patients is sertraline. 
• In  meta-analysis, No difference between the 2 treatment 
groups was demonstrated   
Use of antidepressant drugs in schizophrenic patients with depression 
Encephale. 2006 

Current evidence : Mood Stabilizers
• Lithium
• Carbamezapine
• Valproic acid
• Lamotregene
• Toperamate
• Gabapentine
• Calcium channel 
blockers
Are atypical neuroleptics 
mood stabilisers?
• Are they effective beyond psychotic 
affective states?
• Are they effective against the depressive 
phase of bipolar disorder?
• Do they induce mania?
• Do they work in mixed states?
• Do they work in rapid cycling?
• Can they prevent suicide?
5 HT System in the Brain 

Depression in schizophrenia : perspective in era of ‘atypical antipsychotics’. Siris ,S.G.AJP 2000 ;157
How do we explain?
Why do Atypical antipsychotics have Antidepressant action?
A: Regional distribution of   5-HT System in the Brain?? 
• Optimizing antipsychotic treatment and atypical antipsychotics 
prove to be most effective
• Adjunctive antidepressants may be useful for patients who are 
not acutely ill
• Careful longitudinal assessment is required to ensure 
identification of primary mood disorders
Relative Efficacy of AAPD for mood symptoms 
and suicidality in Schizophrenia
• Clozapine
• Olanzapine
• Aripiprazole 
• Quetiapine
• Amisulpiride
• Ziprasidone
• Paliperidone
• Risperidone
Increasing
efficacy
CATIE outcome of Mood symptoms
Does quetiapine have mood altering 
properties?
• The data indicate that a side-effect of quetiapine may 
be mood elevation. 
• An ability to elevate mood while controlling 
psychoses would be helpful in the treatment of post-
psychotic and bipolar depression. 
• Its clinical importance in the control of manic 
episodes, for which atypical antipsychotics are used 
increasingly, is uncertain. 
Schizophrenia with associated complications: 
Dysphoria
McEvoy JP. Journal of Clinical Psychiatry 1999;60(11):1-80.
McEvoy JP. Journal of Clinical Psychiatry 1999;60(11):1-80.
Schizophrenia with associated complications: 
Suicidal behavior
1. Kinon et al. J Clin Psychopharm 2006;26:157-62.
MADRS change
p=0.010
HAM-D change YMRS change
6-wk, open-label study in patients with schizoaffective 
disorder, bipolar type (n=102)
24-week, RCT in patients with 
schizophrenia or schizoaffective disorder 
with depressive symptoms (n=394)
CDSS: Calgary Depression Scale for Schizophrenia 
MADRS: Montgomery-Asberg Depression Rating 
Scale
CDSS change
p=0.105
Atypical Antipsychotics: Improvement 
in Depressive Symptoms
HAM-D: Hamilton Rating Scale for Depression; 
HAM-A: Hamilton Rating Scale for Anxiety
Depression
1. Strous et al. Hum Psychopharm 2006;21:235-43.
Anxiety
12-week, naturalistic, observational study
Switching Antipsychotics May Improve 
Depressive Symptoms
1.De Nayer et al. Int J Psych Clin Pract 2003;7:59-66.
CDSS: Calgary Depression Scale for Schizophrenia
Subgroup with clinically significant depressive symptoms at baseline
CDSS score ≤6 represents
NO clinical depression
* p ≤0.001
Quetiapine
SPECTRUM, 12-wk, open trial in 
patients with schizophrenia 
switched to quetiapine (n=509)
Current evidence : ECT
J ECT. 2006 Jun;22(2):127-32.
Role of Adjunctive Therapies for Mood 
Symptoms.
• Schizoaffective disorder
– Lithium: little evidence of benefit for 
manic type
– Antidepressants: Antipsychotic + AD 
equal or less effective than 
antipsychotic alone 
– Anticonvulsants: No evidence of benefit
1. Levinson et al. Am J Psychiatry 1999;156:1138-
48.
–Antidepressants2,3
•Acutely: no advantage of 
antipsychotic + AD vs. 
antipsychotic alone
•Post-psychotic MDD: 
adjunctive AD may be useful
• Optimizing antipsychotic 
treatment is likely a more 
effective strategy for mood 
symptoms
1. Leucht et al. J Clin Psychiatry 2004;65:177-86. 2.  Levinson et 
al. Am J Psychiatry 1999;156:1138-48. 3.  Whitehead et al.
Cochrane Database Syst Rev 2002:CD002305.
Psychosocial Interventions in 
Schizophrenia
 Proven effective adjuncts to 
pharmacotherapy1
 Social skills training
 Cognitive remediation
 Psychoeducational coping-oriented interventions                              
with families & relatives
 Cognitive behavioural therapy
1.  Pfammatter et al. Schizophr Bull 2006;32 Suppl 1:S64-80. 2.  Jaeger et al. Aust N Z J Psychiatry
2006;40:452-61. 3.  Lysaker et al. J Rehabil Res Dev 2005;42:673-82. 4.  Pitschel-Walz et al. J Clin 
Psychiatry 2006;67:443-52.
Comprehensive Treatment Programs
 Specialized early intervention approach can 
provide:1,2
 ↑ short-term clinical and functional outcomes
 ↑ retention in treatment
 ↓ relapse rates
 ↑ satisfaction with service delivery
 ↑ greater family involvement
 ↑ QoL
1.  Malla et al. Can J Psychiatry 2005;50:881-91. 2.  Harvey et al. Can J 
Psychiatry 2007;52:464-72.
Future Classification of mental 
disorders: Hypothesis: From 
1933 to 2008
Why does suicide occur in psychosis?
What is clinical relevance of this context?
Evidence for  occurrence of depression 
before suicide attempt
1.Biological findings
2.Psychological theories
3. Epidemiological findings
4.Postmartum studies
5.Post-vention  studies
There is evidence 
Of depressed mood
In 98% subjects who 
Successfully kill themselves
      

Prevention of Suicide in Psychotic Disorders:
General principles and strategies.
Term ‘Discharge’ is a misnomer. 
It is actually ‘transfer of Care from Hospital to Community’  
It is a dynamic Process’ .
It is just a mile stones on Continuous spectrum of care
Review: Assessment, Outcome, Care 
Plan, Discharge Plan, Risk 
Management & Transfer of care
Documentation


Prevention of Suicide in Psychotic Disorders: General principles 
and strategies.

Prevention of Suicide in Psychotic Disorders: General 
principles and strategies.
Conclusions: 
Schizoaffective disorders. 
There are many unanswered questions
• Mood symptoms are common, responsive and severe.
• Schizoaffective disorder is a severe psychotic disorder with 
disability, burden and complications.
• Schizoaffective Disorder is an inconsistent condition and does 
not deserve an independent diagnosis
• We are moving towards unitary theory for single-severe-
psychotic-disorder, based on clinical and biological evidences
• Treatment appears inadequate and unclear, but optimizing 
atypicals APD appears best option.
• Clozapine has a special efficacy.
